Full Press Release Details
GAITHERSBURG, Md.,Jan. 7, 2026/PRNewswire/ -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will participate in the 44thAnnual J.P. Morgan Healthcare Conference.
A webcast of the presentation will be available on the Events & Presentations page of the Company's website atir.novavax.com.A replay of the webcast will be available for 30 days.
About NovavaxNovavax, Inc. (Nasdaq:NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M®adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visitnovavax.comandLinkedInfor more information.
Contacts:
InvestorsLuis Sanay, CFA240-268-2022[email protected]
MediaYvonne Sprow240-720-7804[email protected]
SOURCE Novavax, Inc.
| Conference Details: | |
| Presentation | |
| Date: | Wednesday, January 14, 2026 |
| Time: | 4:30 p.m. Pacific Time |
| Location: | San Francisco, CA |